Table: begin end state 1 11 cytoplasmic 12 29 transmembrane 30 40 non-cytoplasmic 41 60 transmembrane 61 93 cytoplasmic 94 119 transmembrane 120 125 non-cytoplasmic 126 144 transmembrane 145 157 cytoplasmic 158 178 transmembrane 179 201 non-cytoplasmic 202 221 transmembrane 222 232 cytoplasmic 233 256 transmembrane 257 280 non-cytoplasmic 281 310 transmembrane 311 331 cytoplasmic 332 352 transmembrane 353 357 non-cytoplasmic 358 381 transmembrane 382 396 cytoplasmic 397 413 transmembrane 414 418 non-cytoplasmic 419 437 transmembrane 438 448 cytoplasmic 449 469 transmembrane 470 475 non-cytoplasmic
Input: >PP_1003 MSEPGQKLRLGALIALVVGSMIGGGIFSLPQNMAARADVGAVLIGWGITAVGMLALAFVF QTLANRKPELDSGVYAYAKAGFGEYMGFSSAWGYWISAWLGNVGYFVLLFSTLGFYFPVF GEGNTPIAIGCASLLLWSVHFLVLRGIKEAAFINQVTTVAKVVPLLIFVVIAAFAFRADI FTRDIWGLSNPQFGSVLEQVRNMMLVTVFVFIGIEGASVYSGRAQRRSDVGKATVIGFLG VLALLVLVNVLSLGIMTQPELAGLQNPSLASVLEHIVGPWGALLISLGLAVSLLGALLSW ALLCAEILYATARDKTMPRFLAKENANHVPANALWLTNCMIQGFLLITLFSAGTYTSLIY LASSMILVPYLWSAAYAVLLAMRAETYAGQPRLRRKDLLVALVALLYAVWLLYAGGLKYL LLSALLYAPGVILFARAKHEQGQTLFTAWEKLIFAAVLVGAALAAYALYSGLLSL
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server